Clinical Report Addresses Need for POCUS Guidelines for NICU
MONDAY, Nov. 28, 2022 (HealthDay News) — A point-of-care ultrasonography (POCUS) program should be developed for use in the neonatal intensive care unit (NICU), according to a clinical report published online Nov. 28 in Pediatrics.Noting that use of …
Learn MoreQOL Up With Pembrolizumab Versus Ipilimumab, HDI in Resected Melanoma
MONDAY, Nov. 28, 2022 (HealthDay News) — For patients with high-risk resected melanoma, adjuvant pembrolizumab improves quality of life (QOL) compared with standard of care with ipilimumab or high-dose interferon α 2b (HDI), according to a study publ…
Learn MoreUn implante administra quimioterapia directa a los cerebros de los pacientes con tumores cerebrales
MARTES, 22 de noviembre de 2022 (HealthDay News) — Unos investigadores encontraron una forma de administrar de forma segura un suministro de quimioterapia directamente en los tumores cerebrales, y esperan que esto sea un importante avance para los pa…
Learn MoreA Gene Therapy for Hemophilia That Costs $3.5 Million Gets FDA Approval
WEDNESDAY, Nov. 23, 2022 (HealthDay News) — People with one form of the genetic blood disorder hemophilia now have a one-time treatment with a $3.5 million price tag.The U.S. Food and Drug Administration approved the new gene therapy Hemgenix on Nov….
Learn MoreImplant Delivers Chemo Directly to Brain in Patients Battling Brain Tumors
TUESDAY, Nov. 22, 2022 (HealthDay News) — Researchers have found a way to safely deliver a steady supply of chemotherapy directly to brain tumors — in what they hope will be an important advance for patients with currently incurable cancers.The trea…
Learn MoreMeasuring Vertebral Arteries Can Clarify Pathology of Transient Vascular Vertigo
TUESDAY, Nov. 22, 2022 (HealthDay News) — Measuring vertebral arteries (VAs) using color-coded ultrasonography and cervical vestibular-evoked myogenic potential (cVEMP) can help to clarify the pathophysiology of transient vascular vertigo/dizziness (…
Learn MoreOncogenic Variants Identified in ~10 Percent With Appendix Cancer
TUESDAY, Nov. 22, 2022 (HealthDay News) — About 10 percent of patients with appendix cancer (AC) who undergo testing for hereditary cancer disposition harbor a gene sequence variation associated with cancer susceptibility, according to a study publis…
Learn MoreEducation Interacts With Genetic Variants to Increase Myopia Risk
TUESDAY, Nov. 22, 2022 (HealthDay News) — Education interacts with genetic variants to confer susceptibility to myopia, according to a study published online Nov. 17 in PLOS Genetics.Rosie Clark, Ph.D., from Cardiff University in the United Kingdom, …
Learn More¿Compra medicamentos en una farmacia en línea? Tenga cuidado, aconseja la FDA
VIERNES, 18 de noviembre de 2022 (HealthDay News) — Quizá sea tentador comprar medicamentos recetados en línea, pero los compradores deben tener cuidado, advierte la Administración de Alimentos y Medicamentos (FDA) de EE. UU.Aunque algunos sitios web…
Learn MoreLa FDA aprueba el primer medicamento para retrasar el inicio de la diabetes tipo 1
VIERNES, 18 de noviembre de 2022 (HealthDay News) — El jueves, la Administración de Alimentos y Medicamentos (FDA) de EE. UU. aprobó el primer fármaco que podría retrasar el desarrollo de la diabetes tipo 1 (DT1).El teplizumab (Tzield) se dirige a la…
Learn More